GoConqr hat ein neues Design! Sag uns, wie es dir gefällt.

Karteikarten

SU5505 Midterm Test

Annie Nguyen Englisch 41 Karten

SU5505 Midterm Test

Karten in diesem Stapel (41)

  1. 1List the 7 steps for Spirometry interpretation1. Six seconds long
    2. Flow volume loop shape
    3. FEV1/ FVC >70%
    4. FVC > 80%
    5. FEV1 > 80%
    6. ID pattern
    7. Classify Severity
  2. 2—LV hypertrophy: Increased R wave peak time:Left ventricular strain pattern:
    *T wave inversion in the lateral leads V5-6*
    LV hypertrophy: Increased R wave peak time:Left ventricular strain pattern: *T wave inversion in the lateral leads V5-6*
  3. 3Proventil HFA, ProAir, Xopenex is an example of ?SABA: Short- acting beta agonist ( short-acting bronchodilator)
  4. 4Aerospan, Flovent, Pulmicort and Qvar are examples of ?ICS- inhaled corticosteriods
  5. 5Foradil and Serevent are examples of ?LABA
  6. 6Atrovent, Combivent, Tudorza, and Spiriva are examples of ????Anticholinergics
  7. 7Advair, Breo, Dulera, and Symbicort are examples of?????Combo Medications: ICS and LABA
  8. 8Gold Standard DX for COPDSpirometry
  9. 9Diagnostics for Asthma20% variation in PEF (liters/mins)
    Spirometry
  10. 10Peak Flow Measurement 1. Stand___ 2. Cursor at _____ 3. Blow _____& _____ 4. Best of _____ attempts 5. Record _______ best.1. Stand up
    2. Cursor at zero
    3. Blow hard & fast
    4. Best of 3 attempts
    5. Record personal best.
  11. 11Deaths from Asthma is best reduced by.... 1. written _______ plan 2. Oral _______ prior to severe attack 3. Use of Peak _____ meter ( Liters/mins.)1. written Action plan
    2. Oral corticosteroids prior to severe attack
    3. Use of Peak Flow meter ( Liters/mins.)
  12. 12This type of Asthma Medication benefits those who are obese, smoke, or triad of asthmaLeukotriene medications: SingulairThis type of Asthma Medication benefits those who are obese, smoke, or triad of asthma
  13. 13Triad Asthma criteriaNasal polyps
    ASA sensitivity
    Severe asthma
  14. 14Asthma Control Test A score of ____ is controlled asthmatic.<19 not controlled
    >20 is well controlled
  15. 15What medication increase the risk of pneumonia in COPD patients?Corticosteroid do not cause Pneumonia or osteoporosis in asthmatics, however those with COPD .
  16. 16Peak Flow Monitoring 1. best lung function __ pm & lowest __am 2. ___% fluctuation is healthy 3. ___% variation DX of asthma 4. NOT USED FOR _____.1. best lung function 4 pm & lowest 4am
    2. 8% fluctuation is healthy
    3. 20% variation DX of asthma
    4. NOT USED FOR COPD.
    * effort dependent*
  17. 17Schedule of Asthma Follow up 1st F/U within ____ month. Routine visit ___ to ___ months.1st F/U within 1 month.
    Routine visit 1 to 6 months.
    *assess correct use of inhaler, spacer, peak flow meter (PFM)*
  18. 18COPD is not fully ________.COPD is not fully reversible.
    Preventable and treatable.
  19. 19Productive cough for 3 consecutive months for 2 consecutive years.Chronic Bronchitis
  20. 20COPD SOB manifest at __ % of lung functionSOB manifest at 50 % of lung function
  21. 21PATHO of COPD 1. increases in ______ and neutrophils. 2. ______ hyperplasia. 3. Bronchiolar ______. 4. Peribronchiolar ________. 5. Loss of _______ attachments.1. increases in macrophages and neutrophils.
    2. bronchiolar hyperplasia.
    3. Bronchiolar edema.
    4. Peribronchiolar fibrosis.
    5. Loss of alveolar attachments.
  22. 22COPD presentation 1. SXS present at 1 PPD for > ____ years. 2. manifestation at _____ decade: chronic cough after viral infx. 3. Dypsnea at ___ or ____ decade.1. SXS present at 1 PPD for > 20 years.
    2. manifestation at fifth decade: chronic cough after viral infx.
    3. Dypsnea at sixth or seventh decade.
  23. 23COPD Physical Exam 1. ______ and _____ expiration. 2. Chest wall _______inflation. 3. Distant _____ and ____ sounds. 4. Pursed ____ breathing. 5. Cor ______: JVD, edema, heptomegaly1. Slow and prolonged expiration.
    2. Chest wall hyperinflation.
    3. Distant heart and breath sounds.
    4. Pursed lip breathing.
    5. Cor pulmonale: JVD, edema, heptomegaly
  24. 24COPD Chest XrayCOPD Chest XRAY
    1. flat diaphragm
    2. tear shaped heart
    3. Increase AP/ retrosternal airspace
    *Emphysema: pruning of pulmonary vessels and bullae*
    COPD Chest Xray
  25. 25COPD assessment test (CAT) < 10 > 10Group A: low risk, less SXS (CAT< 10)
    Group B: low risk, more SXS (CAT>10)
    Group C: high risk, less SXS (CAT< 10)
    Group D: high risk, high SXS (CAT >10)
    *GROUP B &D: 5x risk for cardiovascular dx and cancer*
  26. 26COPD Treatment : 1st Choice Group A and BGroup A: SAAC (Atrovent/ combivent) or
    SABA (Proair, Proventil)
    Group B: LAAC (spiriva/anora ) or LABA (Foradil/ Serevent)
    * add- on exercise and pulmonary rehab*
  27. 27COPD 1st choice treatment for Group C and DGroup C: LAAC (Anora/Spriva) and (+)LABA ( Foradil/Serevent)
    Group D: ICS (Flovent/ Pulmicort) and(+)LABA or LAAC
    * add- on exercise, oxygen therapy pulmonary rehab*
  28. 28Spirometry List the predicted values/ criteria.1. Gender
    2. Race
    3. Age
    4. height
  29. 29____ _____ _____ (FVC) maximum volume of air exhaled _____ _____ ______ (FEV1): volume exhaled during the first second.Forced Vital Capacity: maximum volume of air exhaled
    Forced Expiratory Volume: volume exhaled during the first second.
  30. 30Normal Lung Volume Values FEV / FVC1 >____% FVC > _____% FEV1 > _____%Normal Lung Volume Values
    FEV / FVC1 >70%
    FVC > 80 %
    FEV1 > 80 %
  31. 31Obstructive vs Restrictive Disease pattern Obstructive: FEV1 / FVC _____, FVC _____ FEV1_____Obstructive: FEV1 / FVC down , FVC normal, FEV1 down
  32. 32Obstructive vs Restrictive Disease pattern Restrictive : FEV1 / FVC _____, FVC _____ FEV1_____Restrictive : FEV1 / FVC normal , FVC down FEV1 down
    Combined:FEV1 / FVC down, FVC down, FEV1 down
  33. 33Obstructive Lung DiseasesAsthma
    COPD
    Bronchiectasis
    Cystic Fibrosis
  34. 34Obstructive Reversibility defined as a change of ____% post Albuterol (SABA) or Ipratropium (Atrovent) and increase of _______ mL.Obstructive Reversibility
    defined as a change of 12 % post Albuterol (SABA) or Ipratropium (Atrovent) and increase of 200 mL.
  35. 35CAD inflammation marker. < 1 low risk for CV events 1-3 intermediate >3 highHigh Sensitivity CRP (hs-CRP)
  36. 36Which is an independent risk factor for CHD? HDL, LDL, TriglyceridesElevated Triglycerides are an independent risk factor for CHD. Low HDL independent predictor
    (inverse relationship)
    Normal < 150
    Borderline 150-199
    High > 200- increased risk for pancreatitis
  37. 37What are the criteria for Metabolic syndrome? Metabolic syndrome- 3+SXS to DX1. Abdominal obesity (M >40in. W> 35)
    2. Triglyceride> 150 mg/dl
    3. Low HDL ( M<40, W< 50)
    4. High BP ( 130/85)
    5. Fast blood glucose (> 110)
  38. 38DXD for Dyslipidemia1. DM
    2. Hypothyroidism
    3. obstructive liver dx
    4. Chronic renal failure
    5. Protease inhibitor ( HIV meds)
    6. BBB, HCTZ= low HDL
    7. Prednisone ( high TG)
    8. Tamoxifen- high TG ( Breast CA)
  39. 39—Non occlusive thrombus
    unstable angina and non-Q wave MI
    Non occlusive thrombus unstable angina and non-Q wave MI
  40. 40—Occlusive thrombus
    Q wave MI and sudden death
    Occlusive thrombus Q wave MI and sudden death
  41. 41—

Informationen

Beschreibung
ANP: LUNG and Heart
Erstellt von
Annie Nguyen
Aufrufe
79
Bewertung

Feedback

Worum geht es?

Wie gefällt dir das neue Design?

Dein Eindruck